{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33344645", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "16"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "12", "Day": "01"}], "Language": ["eng"], "ELocationID": ["6940953", "10.1155/2020/6940953"], "Journal": {"ISSN": "2314-6141", "JournalIssue": {"Volume": "2020", "PubDate": {"Year": "2020"}}, "Title": "BioMed research international", "ISOAbbreviation": "Biomed Res Int"}, "ArticleTitle": "Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances.", "Pagination": {"StartPage": "6940953", "MedlinePgn": "6940953"}, "Abstract": {"AbstractText": ["Plumbagin (PLB), a natural naphthoquinone constituent isolated from the roots of the medicinal plant <i>Plumbago zeylanica</i> L., exhibited anticancer activity against a variety of cancer cell lines including breast cancer, hepatoma, leukemia, melanoma, prostate cancer, brain tumor, tongue squamous cell carcinoma, esophageal cancer, oral squamous cell carcinoma, lung cancer, kidney adenocarcinoma, cholangiocarcinoma, gastric cancer, lymphocyte carcinoma, osteosarcoma, and canine cancer. PLB played anticancer activity <i>via</i> many molecular mechanisms, such as targeting apoptosis, autophagy pathway, cell cycle arrest, antiangiogenesis pathway, anti-invasion, and antimetastasis pathway. Among these signaling pathways, the key regulatory genes regulated by PLB were NF-k<i>\u03b2</i>, STAT3, and AKT. PLB also acted as a potent inducer of reactive oxygen species (ROS), suppressor of cellular glutathione, and novel proteasome inhibitor, causing DNA double-strand break by oxidative DNA base damage. This review comprehensively summarizes the anticancer activity and mechanism of PLB."], "CopyrightInformation": "Copyright \u00a9 2020 Zhenhua Yin et al."}, "AuthorList": [{"Identifier": ["0000-0002-4982-3230"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhengzhou Key Laboratory of Medicinal Resources Research, Huanghe Science and Technology College, Zhengzhou 450063, China."}, {"Identifier": [], "Affiliation": "Henan Joint International Research Laboratory of Drug Discovery of Small Molecules, Zhengzhou 450063, China."}], "LastName": "Yin", "ForeName": "Zhenhua", "Initials": "Z"}, {"Identifier": ["0000-0003-2982-2668"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhengzhou Key Laboratory of Medicinal Resources Research, Huanghe Science and Technology College, Zhengzhou 450063, China."}, {"Identifier": [], "Affiliation": "Henan Joint International Research Laboratory of Drug Discovery of Small Molecules, Zhengzhou 450063, China."}], "LastName": "Zhang", "ForeName": "Juanjuan", "Initials": "J"}, {"Identifier": ["0000-0002-1454-8275"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhengzhou Key Laboratory of Medicinal Resources Research, Huanghe Science and Technology College, Zhengzhou 450063, China."}, {"Identifier": [], "Affiliation": "Henan Joint International Research Laboratory of Drug Discovery of Small Molecules, Zhengzhou 450063, China."}], "LastName": "Chen", "ForeName": "Lin", "Initials": "L"}, {"Identifier": ["0000-0002-7864-9067"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhengzhou Key Laboratory of Medicinal Resources Research, Huanghe Science and Technology College, Zhengzhou 450063, China."}, {"Identifier": [], "Affiliation": "Henan Joint International Research Laboratory of Drug Discovery of Small Molecules, Zhengzhou 450063, China."}], "LastName": "Guo", "ForeName": "Qingfeng", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhengzhou Key Laboratory of Medicinal Resources Research, Huanghe Science and Technology College, Zhengzhou 450063, China."}, {"Identifier": [], "Affiliation": "Henan Joint International Research Laboratory of Drug Discovery of Small Molecules, Zhengzhou 450063, China."}], "LastName": "Yang", "ForeName": "Baocheng", "Initials": "B"}, {"Identifier": ["0000-0002-8583-3540"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhengzhou Key Laboratory of Medicinal Resources Research, Huanghe Science and Technology College, Zhengzhou 450063, China."}], "LastName": "Zhang", "ForeName": "Wei", "Initials": "W"}, {"Identifier": ["0000-0002-1822-6249"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhengzhou Key Laboratory of Medicinal Resources Research, Huanghe Science and Technology College, Zhengzhou 450063, China."}, {"Identifier": [], "Affiliation": "National R&D Center for Edible Fungus Processing Technology, Henan University, Kaifeng 475004, China."}], "LastName": "Kang", "ForeName": "Wenyi", "Initials": "W"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biomed Res Int", "NlmUniqueID": "101600173"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Liposomes"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthoquinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Proteasome Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "11062-77-4", "NameOfSubstance": "Superoxides"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}, {"RegistryNumber": "YAS4TBQ4OQ", "NameOfSubstance": "plumbagin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "DNA Breaks, Double-Stranded"}, {"QualifierName": [], "DescriptorName": "DNA Damage"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glutathione"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["chemistry"], "DescriptorName": "Liposomes"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Naphthoquinones"}, {"QualifierName": [], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Oxidants"}, {"QualifierName": ["chemistry"], "DescriptorName": "Oxygen"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Proteasome Inhibitors"}, {"QualifierName": [], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Superoxides"}], "CoiStatement": "The authors declare that they have no conflict of interest, financial or otherwise."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zheng W., Tao Z., Chen C., et al. Plumbagin prevents IL-1\u03b2-induced inflammatory response in human osteoarthritis chondrocytes and prevents the progression of osteoarthritis in mice. Inflammation. 2017;40(3):849\u2013860. doi: 10.1007/s10753-017-0530-8.", "ArticleIdList": ["10.1007/s10753-017-0530-8", "28168658"]}, {"Citation": "Shao Y., Dang M., Lin Y., Xue F. Evaluation of wound healing activity of plumbagin in diabetic rats. Life Sciences. 2019;231:p. 116422. doi: 10.1016/j.lfs.2019.04.048.", "ArticleIdList": ["10.1016/j.lfs.2019.04.048", "31059689"]}, {"Citation": "Gwee P. S., Khoo K. S., Ong H. C., Sit N. W. Bioactivity guided isolation and structural characterization of the antifungal compound\uff0cplumbagin, from Nepenthes gracilis. Pharmaceutical Biology. 2014;52(12):1526\u20131531. doi: 10.3109/13880209.2014.902083.", "ArticleIdList": ["10.3109/13880209.2014.902083", "25026359"]}, {"Citation": "Kaewbumrung S., Panichayupakaranant P. Antibacterial activity of plumbagin derivative rich Plumbago indica root extracts and chemical stabilit. Natural Product Research. 2019;28(11):35\u2013837.", "ArticleIdList": ["24483166"]}, {"Citation": "Sharma I., Gusain D., Dixit V. Hypolipidaemic and antiatherosclerotic effects of plumbagin in rabbits. Indian Journal of Physiology and Pharmacology. 1991;35(1):10\u201314.", "ArticleIdList": ["1917004"]}, {"Citation": "Luo P., Wong Y. F., Ge L., et al. Anti-inflammatory and analgesic effect of plumbagin through inhibition of nuclear Factor-\u03baB activation. Journal of Pharmacology and Experimental Therapeutics. 2010;335(3):735\u2013742. doi: 10.1124/jpet.110.170852.", "ArticleIdList": ["10.1124/jpet.110.170852", "20858709"]}, {"Citation": "Qiao H., Wang T. Y., Tang T. T. Advances in tumor suppression by plumbagin and it mechanism. Tumori. 2014;34(10):957\u2013962."}, {"Citation": "Tripathi S. K., Panda M., Biswal B. K. Emerging role of plumbagin: cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food and Chemical Toxicology. 2019;125:566\u2013582. doi: 10.1016/j.fct.2019.01.018.", "ArticleIdList": ["10.1016/j.fct.2019.01.018", "30685472"]}, {"Citation": "Sameni S., Hande M. P. Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells. Biomedicine & Pharmacotherapy. 2016;82:256\u2013268. doi: 10.1016/j.biopha.2016.05.007.", "ArticleIdList": ["10.1016/j.biopha.2016.05.007", "27470362"]}, {"Citation": "Binoy A., Nedungadi D., Katiyar N., et al. Plumbagin induces paraptosis in cancer cells by disrupting the sulfhydryl homeostasis and proteasomal function. Chemico-Biological Interactions. 2019;310:p. 108733. doi: 10.1016/j.cbi.2019.108733.", "ArticleIdList": ["10.1016/j.cbi.2019.108733", "31276663"]}, {"Citation": "Sakunrangsit N., Kalpongnukul N., Pisitkun T., Ketchart W. Plumbagin enhances tamoxifen sensitivity and inhibits tumor invasion in endocrine resistant breast cancer through EMT regulation. Phytotherapy Research. 2016;30(12):1968\u20131977. doi: 10.1002/ptr.5702.", "ArticleIdList": ["10.1002/ptr.5702", "27530731"]}, {"Citation": "Kawiak A., Domachowska A. Plumbagin suppresses the invasion of HER2-overexpressing breast cancer cells through inhibition of IKK\u03b1-mediated NF-\u03baB activation. PLoS One. 2016;11(10, article e0164064)", "ArticleIdList": ["PMC5058502", "27727280"]}, {"Citation": "Messeha S. S., Zarmouh N. O., Mendonca P., Alwagdani H., Kolta M. G., Soliman K. F. A. The inhibitory effects of plumbagin on the NF-\u049bB pathway and CCL2 release in racially different triple-negative breast cancer cells. PLoS One. 2018;13(7):1\u201325.", "ArticleIdList": ["PMC6066199", "30059519"]}, {"Citation": "Srinivas P., Gopinath G., Banerji A., Dinakar A., Srinivas G. Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells. Molecular Carcinogenesis. 2004;40(4):201\u2013211. doi: 10.1002/mc.20031.", "ArticleIdList": ["10.1002/mc.20031", "15264212"]}, {"Citation": "Somasundaram V., Hemalatha S. K., Pal K., et al. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells. BMC Cancer. 2016;16(1):336\u2013336. doi: 10.1186/s12885-016-2372-4.", "ArticleIdList": ["10.1186/s12885-016-2372-4", "PMC4882782", "27229859"]}, {"Citation": "Nair R. S., Kumar J. M., Jose J., et al. Increased sensitivity of BRCA defective triple negative breast tumors to plumbagin through induction of DNA double strand breaks (DSB) Scientific Reports. 2016;6(1):p. 26631.", "ArticleIdList": ["PMC4879579", "27220670"]}, {"Citation": "Kuete V., Omosa L. K., Sipowo Tala V. R., et al. Cytotoxicity of plumbagin, rapanone and12 other naturally occurring quinones from Kenyan Flora towards human carcinoma cells. BMC Pharmacology and Toxicology. 2016;17:p. 60.", "ArticleIdList": ["PMC5175396", "27998305"]}, {"Citation": "De U., Son J. Y., Jeon Y., et al. Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells. Food and Chemical Toxicology. 2019;123:492\u2013500. doi: 10.1016/j.fct.2018.11.040.", "ArticleIdList": ["10.1016/j.fct.2018.11.040", "30458268"]}, {"Citation": "Qiao H., Wang T.-y., Yan W., et al. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro. Acta Pharmacologica Sinica. 2015;36(9):1085\u20131098. doi: 10.1038/aps.2015.42.", "ArticleIdList": ["10.1038/aps.2015.42", "PMC4561967", "26235741"]}, {"Citation": "Qiao H., Wang T., Yu Z., et al. Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model. Cell Death and Disease. 2016;7(2, article e2094) doi: 10.1038/cddis.2016.11.", "ArticleIdList": ["10.1038/cddis.2016.11", "PMC4849151", "26866274"]}, {"Citation": "Kawiak A., Domachowska A., Lojkowska E. Plumbagin increases paclitaxel-induced cell death and overcomes paclitaxel resistance in breast cancer cells through ERK-mediated apoptosis induction. Journal of Natural Products. 2019;82(4):878\u2013885.", "ArticleIdList": ["30810041"]}, {"Citation": "Wei Y. F., Yang Q., Zhang Y., et al. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells. Oncotarget. 2017;8(9):15230\u201315241. doi: 10.18632/oncotarget.14774.", "ArticleIdList": ["10.18632/oncotarget.14774", "PMC5362482", "28122355"]}, {"Citation": "Zhong J., Li J., Wei J., et al. Plumbagin restrains hepatocellular carcinoma angiogenesis by stromal cell-derived factor (SDF-1)/CXCR4-CXCR7 axis. Medical Science Monitor. 2019;25:6110\u20136119. doi: 10.12659/MSM.915782.", "ArticleIdList": ["10.12659/MSM.915782", "PMC6707097", "31415486"]}, {"Citation": "Simao A. Carcinoma Hepatocelular: Dados Portugueses de Doentes com Hepatite B Cronica sob Terapeutica Antiviral e do Tratamento com Sorafenib. GE Portuguese Journal of Gastroenterology. 2016;23(5):231\u2013232. doi: 10.1016/j.jpge.2016.08.001.", "ArticleIdList": ["10.1016/j.jpge.2016.08.001", "PMC5580183", "28868467"]}, {"Citation": "Jia D., Lu W., Zhang X., et al. Calf spleen extractive injection (CSEI), a small peptides enriched extraction, induces human hepatocellular carcinoma cell apoptosis via ROS/MAPKs dependent mitochondrial pathway. Journal of Pharmacological Sciences. 2016;132(2):122\u2013130. doi: 10.1016/j.jphs.2016.08.006.", "ArticleIdList": ["10.1016/j.jphs.2016.08.006", "28314430"]}, {"Citation": "Zhu D. Q., Chen X. J. Effect of plumbagin on proliferation and apoptosis of hepatocellular carcinoma HepG2R cells resistant to sorafinib and its mechanism. Journal of Jilin University (Medicine Edition) 2018;44(6):1223\u20131229."}, {"Citation": "Lin Y., Chen Y., Wang S., et al. Plumbagin induces autophagy and apoptosis of SMMC-7721 cells in vitro and in vivo. Journal of Cellular Biochemistry. 2019;120(6):9820\u20139830.", "ArticleIdList": ["30536473"]}, {"Citation": "Wei Y., Lv B., Xie J., et al. Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3/vimentin signal-mediated EMT. Drug Design Development and Therapy. 2019;13:2343\u20132355. doi: 10.2147/DDDT.S204787.", "ArticleIdList": ["10.2147/DDDT.S204787", "PMC6643260", "31409969"]}, {"Citation": "Sabatini D. M., Erdjument-Bromage H., Lui M., Tempst P., Snyder S. H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell. 1994;78(1):35\u201343. doi: 10.1016/0092-8674(94)90570-3.", "ArticleIdList": ["10.1016/0092-8674(94)90570-3", "7518356"]}, {"Citation": "Heitman J., Movva N. R., Hall M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991;253(5022):905\u2013909. doi: 10.1126/science.1715094.", "ArticleIdList": ["10.1126/science.1715094", "1715094"]}, {"Citation": "Li T., Lv M., Chen X., Yu Y., Zang G., Tang Z. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA. Drug Design Development and Therapy. 2019;13:1289\u20131300. doi: 10.2147/DDDT.S200610.", "ArticleIdList": ["10.2147/DDDT.S200610", "PMC6498963", "31118568"]}, {"Citation": "Arner E. S. Focus on mammalian thioredoxin reductases -- important selenoproteins with versatile functions. Biochimica et Biophysica Acta. 2009;1790(6):495\u2013526. doi: 10.1016/j.bbagen.2009.01.014.", "ArticleIdList": ["10.1016/j.bbagen.2009.01.014", "19364476"]}, {"Citation": "Matsuzawa A. Thioredoxin and redox signaling: roles of the thioredoxin system in control of cell fate. Archives of Biochemistry and Biophysics. 2017;617:101\u2013105.", "ArticleIdList": ["27665998"]}, {"Citation": "Zhang J., Peng S., Li X., Liu R., Han X., Fang J. Targeting thioredoxin reductase by plumbagin contributes to inducing apoptosis of HL-60 cells. Archives of Biochemistry and Biophysics. 2017;619:16\u201326. doi: 10.1016/j.abb.2017.02.007.", "ArticleIdList": ["10.1016/j.abb.2017.02.007", "28249720"]}, {"Citation": "Kong X., Luo J., Xu T., et al. Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi-1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP. Oncology Reports. 2017;37(6):23\u20133432.", "ArticleIdList": ["28498435"]}, {"Citation": "Bae K. J., Lee Y., Kim S. A., Kim J. Plumbagin exerts an immunosuppressive effect on human T-cell acute lymphoblastic leukemia MOLT-4 cells. Biochemical and Biophysical Research Communications. 2016;437(1):272\u2013277.", "ArticleIdList": ["27018383"]}, {"Citation": "Fu C., Gong Y., Shi X., et al. Plumbagin reduces chronic lymphocytic leukemia cell survival by downregulation of Bcl-2 but upregulation of the Bax protein level. Oncology Reports. 2016;36(3):1605\u20131611. doi: 10.3892/or.2016.4950.", "ArticleIdList": ["10.3892/or.2016.4950", "27461100"]}, {"Citation": "Pearlman R. L., Pal H. C., Elmets C. A., Afaq F. Plumbagin induces apoptosis in melanoma cells by ROS-mediated disruption of mitochondrial membrane potential and inhibition of PI3K/AKT/mTOR signaling. Journal of Investigative Dermatology. 2016;136(5):p. 15."}, {"Citation": "Afaq F., Sharma P., McClees S. F., Pearlman R. L., Pal H. C. 817 Plumbagin inhibits melanoma cell growth and tumorigenicity by inducing ER Stress and DDR signaling. Journal of Investigative Dermatology. 2017;137(5):p. S140. doi: 10.1016/j.jid.2017.02.842.", "ArticleIdList": ["10.1016/j.jid.2017.02.842"]}, {"Citation": "Rao B. S. S., Kumar M. R. S., Das S., Aithal K., Udupa N. Radiosensitizing potential of Plumbagin in B16F1 melanoma tumor cells through mitochondrial mediated programmed cell death. Journal of Applied Biomedicine. 2015;13(4):336\u2013336."}, {"Citation": "Gowda R., Sharma A., Robertso G. R. Synergistic inhibitory effects of celecoxib and plumbagin on melanoma tumor growth. Cancer Letter. 2017;385:243\u2013250.", "ArticleIdList": ["27769779"]}, {"Citation": "Hafeez B. B., Fischer J. W., Singh A., et al. Plumbagin inhibits prostate carcinogenesis in intact and castrated PTEN knockout mice via targeting PKC , Stat3, and epithelial-to-mesenchymal transition markers. Cancer Prevention Research. 2015;8(5):375\u2013386. doi: 10.1158/1940-6207.CAPR-14-0231.", "ArticleIdList": ["10.1158/1940-6207.CAPR-14-0231", "PMC4417441", "25627799"]}, {"Citation": "Zhou S.-F., Zhou Z.-W., Li X.-X., et al. Induction of apoptosis and autophagy via sirtuin1-and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells. Drug Design Development and Therapy. 2015;9:1511\u20131554.", "ArticleIdList": ["PMC4366042", "25834399"]}, {"Citation": "Zhou S.-F., Qiu J.-X., Zhou Z.-W., et al. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells. Drug Design Development and Therapy. 2015;9:349\u2013417.", "ArticleIdList": ["PMC4294653", "25609920"]}, {"Citation": "Reshma R. S., Sreelatha K. H., Somasundaram V., et al. Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells. Pharmacological Research. 2016;105:134\u2013145. doi: 10.1016/j.phrs.2016.01.012.", "ArticleIdList": ["10.1016/j.phrs.2016.01.012", "26808083"]}, {"Citation": "Abedinpour P., Baron V. T., Chrastina A., et al. Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: a pre-clinical study. The Prostate. 2017;77(16):1550\u20131562. doi: 10.1002/pros.23428.", "ArticleIdList": ["10.1002/pros.23428", "28971491"]}, {"Citation": "Rondeau G., Abedinpour P., Chrastina A., Pelayo J., Borgstrom P., Welsh J. Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells. Science Report. 2018;8(1):p. 2694. doi: 10.1038/s41598-018-20451-9.", "ArticleIdList": ["10.1038/s41598-018-20451-9", "PMC5807367", "29426892"]}, {"Citation": "Laoukili J., Kooistra M. R. H., Br\u00e1s A., et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nature Cell Biology. 2015;7(2):126\u2013136.", "ArticleIdList": ["15654331"]}, {"Citation": "Chen X., Muller G. A., Quaas M., et al. The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism. Molecular and Cellular Biology. 2012;33(2):227\u2013236.", "ArticleIdList": ["PMC3554121", "23109430"]}, {"Citation": "Liu X., Cai W., Niu M., et al. Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1. Journal of Neuro-oncology. 2015;121(3):469\u2013477. doi: 10.1007/s11060-014-1664-2.", "ArticleIdList": ["10.1007/s11060-014-1664-2", "25528634"]}, {"Citation": "Niu M., Cai W., Liu H., et al. Plumbagin inhibits growth of gliomas _in vivo_ via suppression of FOXM1 expression. Journal of Pharmacological Sciences. 2015;128(3):131\u2013136. doi: 10.1016/j.jphs.2015.06.005.", "ArticleIdList": ["10.1016/j.jphs.2015.06.005", "26154848"]}, {"Citation": "Shin S.-S., Park S.-S., Hwang B., et al. MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways. Oncology Reports. 2016;36(4):2313\u20132320. doi: 10.3892/or.2016.5052.", "ArticleIdList": ["10.3892/or.2016.5052", "27573859"]}, {"Citation": "Mart\u00edn-Orozco R., Almaraz-Pro C., Rodr\u00edguez-Ubreva F. J., et al. EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of P13K/Akt. Neoplasia. 2007;9(8):614\u2013624. doi: 10.1593/neo.07337.", "ArticleIdList": ["10.1593/neo.07337", "PMC1950431", "17898861"]}, {"Citation": "Chen G., Yue Y., Qin J., Xiao X., Ren Q., Xiao B. Plumbagin suppresses the migration and invasion of glioma cells via downregulation of MMP-2/9 expression and inaction of PI3K/Akt signaling pathway _in vitro_. Journal of Pharmacological Sciences. 2017;134(1):59\u201367. doi: 10.1016/j.jphs.2017.04.003.", "ArticleIdList": ["10.1016/j.jphs.2017.04.003", "28506595"]}, {"Citation": "Kapoor U., Lenka N. Plumbagin: putative mechanisms of action mediating cells cycle, metabolism, and apoptosisin glioblastoma cells. Free Radical Biology and Medicine. 2017;112:p. 92."}, {"Citation": "Khaw A. K., Sameni S., Venkatesan S., Kalthur G., Hande M. P. Plumbagin alters telomere dynamics, induces DNA damage and cell death in human brain tumour cells. Mutation Research-genetic Toxicology and Environmental Mutagenesis. 2015;793:86\u201395. doi: 10.1016/j.mrgentox.2015.06.004.", "ArticleIdList": ["10.1016/j.mrgentox.2015.06.004", "26520377"]}, {"Citation": "Khaw A. K., Hande M. P., Kalthur G. Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells. Journal of Cellular Biochemistry. 2013;114(6):1257\u20131270.", "ArticleIdList": ["23192708"]}, {"Citation": "Majiene D., Kuseliauskyte J., Stimbirys A., Jekabsone A. Comparison of the effect of native 1,4-naphthoquinones plumbagin, menadione, and lawsone on viability, redox status, and mitochondrial functions of c6 glioblastoma cells. Nutrients. 2019;11(6):p. 1294. doi: 10.3390/nu11061294.", "ArticleIdList": ["10.3390/nu11061294", "PMC6628372", "31181639"]}, {"Citation": "Checker R., Patwardhan R. S., Sharma D., et al. Plumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-\u03baB suppression. Inflammation. 2014;37(2):542\u2013554. doi: 10.1007/s10753-013-9768-y.", "ArticleIdList": ["10.1007/s10753-013-9768-y", "24234154"]}, {"Citation": "Chen X. J., Zhang J. G., Wu L. Plumbagin inhibits neuronal apoptosis, intimal hyperplasia and also suppresses TNF-\u03b1/NF-\u03baB pathway induced inflammation and matrix metalloproteinase-2/9 expression in rat cerebral ischemia. Saudi Journal of Biological Sciences. 2018;25(6):1033\u20131039. doi: 10.1016/j.sjbs.2017.03.006.", "ArticleIdList": ["10.1016/j.sjbs.2017.03.006", "PMC6116857", "30174499"]}, {"Citation": "Zhang Q., Zhao S., Zheng W., Fu H., Wu T., Hu F. Plumbagin attenuated oxygen-glucose deprivation/reoxygenation-induced injury in human SH-SY5Y cells by inhibiting NOX4-derived ROS-activated NLRP3 inflammasome. Bioscience, Biotechnology, and Biochemistry. 2020;84(1):134\u2013142. doi: 10.1080/09168451.2019.1664893.", "ArticleIdList": ["10.1080/09168451.2019.1664893", "31490096"]}, {"Citation": "Zhou S.-F., Pan S.-T., Qin Y., et al. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAP-and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. Drug Design Development and Therapy. 2015;9:1601\u20131626.", "ArticleIdList": ["PMC4365758", "25834400"]}, {"Citation": "Zhou F., Pan S. T., Qiu J. X. Plumbagin enhances the inhibition effects of PF chemotherapy regimen on tongue squamous cell carcinoma cells via PI3K/AKT/mTOR-mediated pathway. Journal of Practical Stomatology. 2018;34(4):512\u2013517."}, {"Citation": "Ono T., Ota A., Ito K., et al. Plumbagin suppresses tumor cell growth in oral squamouscell carcinoma cell lines. Oral Diseases. 2015;21(4):501\u2013511.", "ArticleIdList": ["25580997"]}, {"Citation": "Oh S., Kim H., Nam K., Shin I. Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells. Journal of Biochemistry and Molecular Biology. 2017;50(3):132\u2013137.", "ArticleIdList": ["PMC5422025", "27931517"]}, {"Citation": "Koch A., Lang S. A., Wild P. J., et al. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells. Oncotarget. 2015;6(32):32748\u201332760. doi: 10.18632/oncotarget.4977.", "ArticleIdList": ["10.18632/oncotarget.4977", "PMC4741727", "26293674"]}, {"Citation": "Na S., Zhang J., Zhou X., et al. Plumbagin-mediating GLUT1 suppresses the growth of human tongue squamous cell carcinoma. Oral Diseases. 2018;24(6):920\u2013929. doi: 10.1111/odi.12799.", "ArticleIdList": ["10.1111/odi.12799", "29080392"]}, {"Citation": "Zhou X. M., Na S., Pan S., Qiu J. Effect of plumbagin on invasion and migration of tongue squamous cell carcinoma cells and its mechanism. Journal Oral Science Research. 2018;34(1):39\u201343."}, {"Citation": "Liu M., Dai B., Kang S.-H., et al. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Research. 2006;66(7):3593\u20133602. doi: 10.1158/0008-5472.CAN-05-2912.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-2912", "16585184"]}, {"Citation": "Takata A., Takiguchi S., Okada K., et al. Clinicopathological and prognostic significance of FOXM1 expression in esophageal squamous cell carcinoma. Anticancer Research. 2014;34(5):2427\u20132432.", "ArticleIdList": ["24778055"]}, {"Citation": "Liu Z. D., Zhao Z. W., Chen Y. J. Plumbagin influences the proliferation and apoptosis of esophageal squamous carcinoma cell lines by down-regulation of FoxM1 expression. Acta Pharmaceutica Sinica. 2017;52(4):563\u2013568."}, {"Citation": "Zhang Y., Du X.-L., Wang C.-J., et al. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. Gastroenterology. 2012;142(3):521\u2013530.e3. doi: 10.1053/j.gastro.2011.11.023.", "ArticleIdList": ["10.1053/j.gastro.2011.11.023", "22108192"]}, {"Citation": "Feng Y.-B., Lin D.-C., Shi Z.-Z., et al. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma. International Journal of Cancer. 2009;124(3):578\u2013588.", "ArticleIdList": ["19004025"]}, {"Citation": "Cao Y.-Y., Yu J., Liu T.-T., et al. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling. Cell Death and Disease. 2018;9(2):p. 17.", "ArticleIdList": ["PMC5833725", "29339720"]}, {"Citation": "Kang C. G., Im E., Lee H.-J., Lee E.-O. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice. Bioorganic & Medicinal Chemistry Letters. 2017;27(9):1914\u20131918.", "ArticleIdList": ["28359791"]}, {"Citation": "Liu F., Xie J., Li F., Guo X. Anticancer effect and mechanism of plumbagin on Lewis lung carcinoma in vitro and in vivo. Chinese Palharmaceutic Journal. 2017;52(7):581\u2013586."}, {"Citation": "Geiger J. L., Grandis J. R., Bauman J. E. The STAT3 pathway as a therapeutic target in head and neck cancer: barriers and innovations. Oral Oncology. 2016;56:84\u201392.", "ArticleIdList": ["PMC5590227", "26733183"]}, {"Citation": "Yu T., Xu Y.-Y., Zhang Y.-Y., Li K.-Y., Shao Y., Liu G. Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6/STAT3 signaling in vitro. International Immunopharmacology. 2018;55:290\u2013296.", "ArticleIdList": ["29294439"]}, {"Citation": "Mancilla I. A., Coatti G. C., Biazi B. I., et al. Molecular pathways related to the control of proliferation and cell death in 786-O cells treated with plumbagin. Molecular Biology Reports. 2019;46(6):6071\u20136078.", "ArticleIdList": ["31456160"]}, {"Citation": "Panrit L., Plengsuriyakarn T., Martviset P., Na-Bangchang K. Inhibitory activities of plumbagin on cell migration and invasion and inducing activity on cholangiocarcinoma cell apoptosis. Asian Pacific Journal of Tropical Medicine. 2018;11(7):p. 430."}, {"Citation": "Joo M. K., Park J.-J., Kim S. H., et al. Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells. International Journal of Oncology. 2015;46(6):2380\u20132388.", "ArticleIdList": ["25815436"]}, {"Citation": "Checker R., Gambhir L., Sharma D., Kumar M., Sandur S. K. Plumbagin induces apoptosis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phosphatases (MKP1/2) Cancer Letters. 2015;357(1):265\u2013278.", "ArticleIdList": ["25444924"]}, {"Citation": "Tian L., Liu X., Guo Z., Wang H., Zhang T. Effects of plumbagin on invasion in osteosarcoma cell line MG 63 and its possible mechanisms. Chinese Journal of Oncology Prevention and Treatment. 2016;8(3):137\u2013140."}, {"Citation": "Tian L., Liu X., Guo Z., Wang H., Zhang T. Inhibitory effect of plumbagin on invasion and expression of matrix metalloproteinases in osteosarcoma cells in vitro. Guangdong Medical Journal. 2016;37(19):2872\u20132875."}, {"Citation": "Tian L. Q., Liu X. T., Wang H. W., Guo Z., Zhang T. Effect of plumbagin on proliferation and apoptosis of osteosarcoma cells and its mechanism. Plumbagin. Shandong Medical Journal. 2017;57(12):42\u201344."}, {"Citation": "Comellas A. P., Dada L. A., Lecuona E., et al. Hypoxia-mediated degradation of Na,K-ATPase via mitochondrial reactive oxygen species and the ubiquitinconjugating system. Circulation Research. 2006;98(10):1314\u20131322.", "ArticleIdList": ["16614303"]}, {"Citation": "Gusarova G. A., Dada L. A., Kelly A. M., et al. Alpha1-AMP-activated protein kinase regulates hypoxia-induced Na,K- ATPase endocytosis via direct phosphorylation of protein kinase C zeta. Molecular & Cellular Biology. 2009;29(13):3455\u20133464.", "ArticleIdList": ["PMC2698765", "19380482"]}, {"Citation": "Alharbi Y., Kapur A., Felder M., et al. Plumbagin-induced oxidative stress leads to inhibition of Na+/K+-ATPase (NKA) in canine cancer cells. Scientific Reports. 2019;9(1):p. 11471.", "ArticleIdList": ["PMC6685937", "31391478"]}, {"Citation": "Pawar A., Patel R., Arulmozhi S., Bothiraja C. D-\u03b1-Tocopheryl polyethylene glycol 1000 succinate conjugated folic acid nanomicelles: towards enhanced bioavailability, stability, safety, prolonged drug release and synergized anticancer effect of plumbagin. RSC Advances. 2016;6:78106\u201378121."}, {"Citation": "Hsieh Y. J., Lin L. C., Tsai T. H. Measurement and pharmacokinetic study of plumbagin in a conscious freely moving rat using liquid chromatography/tandem mass spectrometry. Journal of Chromatography B. 2006;844(1):1\u20135.", "ArticleIdList": ["16837255"]}, {"Citation": "Sakpakdeejaroen I., Somani S., Laskar P., Mullin M., Duf\u00e8s C. Transferrin-bearing liposomes entrapping plumbagin for targeted cancer therapy. Journal of Interdisciplinary Nanomedicine. 2019;4(2):54\u201371.", "ArticleIdList": ["PMC6619241", "31341642"]}, {"Citation": "Appadurai P., Rathinasamy K. Plumbagin-silver nanoparticle formulations enhance the cellular uptake of plumbagin and its antiproliferative activities. Iet Nanobiotechnology. 2015;9(5):264\u2013272.", "ArticleIdList": ["26435279"]}, {"Citation": "Shen W. Y., Gu Y. Q., Tan M. X. Studies on synthesis, structure, antitumour activity and the interaction with bovine serum albumin of Y (III) complex of plumbagin. Journal of Yulin Normal University (Natural. Science) 2017;38(2):42\u201347."}, {"Citation": "Qiao H., Cui Z. W., Yang S. B. Targeting osteocytes to attenuate early breast cancer bone metastasis by theranostic upconversion nanoparticles with responsive plumbagin release. ACS Nano. 2017;11(4):4857\u20134857.", "ArticleIdList": ["28692257"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "30"}, {"Year": "2020", "Month": "11", "Day": "3"}, {"Year": "2020", "Month": "11", "Day": "19"}, {"Year": "2020", "Month": "12", "Day": "21", "Hour": "6", "Minute": "9"}, {"Year": "2020", "Month": "12", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33344645", "PMC7725562", "10.1155/2020/6940953"]}}], "PubmedBookArticle": []}